Order Article Reprints

Clavo B, Cánovas-Molina A, Federico M, Martínez-Sánchez G, Benítez G, Galván S, Ramallo-Fariña Y, Fabelo H, Cazorla-Rivero S, Lago-Moreno E, et al. Ozone Treatment in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Review of Rationale and Research Directions. Cancers. 2025; 17(14):2278. https://doi.org/10.3390/cancers17142278

Clavo, Bernardino, Angeles Cánovas-Molina, Mario Federico, Gregorio Martínez-Sánchez, Gretel Benítez, Saray Galván, Yolanda Ramallo-Fariña, Himar Fabelo, Sara Cazorla-Rivero, Elba Lago-Moreno, and et al. 2025. "Ozone Treatment in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Review of Rationale and Research Directions" Cancers 17, no. 14: 2278. https://doi.org/10.3390/cancers17142278

Clavo, B., Cánovas-Molina, A., Federico, M., Martínez-Sánchez, G., Benítez, G., Galván, S., Ramallo-Fariña, Y., Fabelo, H., Cazorla-Rivero, S., Lago-Moreno, E., Antonilli, C., Díaz-Garrido, J. A., Jorge, I. J., Marrero-Callico, G., Rodríguez-Abreu, D., & Rodríguez-Esparragón, F. (2025). Ozone Treatment in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Review of Rationale and Research Directions. Cancers, 17(14), 2278. https://doi.org/10.3390/cancers17142278